@Article{Jarząbek2013,
journal="Medical Studies/Studia Medyczne",
issn="1899-1874",
volume="29",
number="3",
year="2013",
title="New oral anticoagulants in the prevention of stroke",
abstract="Atrial fibrillation is associated with a few folds higher risk of stroke. Traditional vitamin K antagonists used in the prevention of stroke in patients with non-valvular atrial fibrillation are often not efficient enough due to their interactions with a broad range of substances including medicines or food ingridients and problems with monitoring the treatment. New oral anticoagulants pose an alternative  for the vitamin K antagonists. They are equally efficient in the prevention of stroke, but are safer and have no requirement for routine coagulation monitoring. We present a case of a patient with atrial fibrillation, high risk of tromboembolism and recurring episodes of hemorrhages. Considering the possible complications, rivaroxaban was administered.",
author="Jarząbek, Konrad
and Bąkowski, Dawid
and Wożakowska-Kapłon, Beata",
pages="264--266",
doi="10.5114/ms.2013.38584",
url="http://dx.doi.org/10.5114/ms.2013.38584"
}